文献速递消化道肿瘤与早癌消化内镜

粪便免疫化学检测阳性结肠镜检查与直接筛查结肠镜检查的腺瘤检出率比较

Adenoma detection rates in colonoscopies for positive fecal immunochemical tests versus direct screening colonoscopies.
PubMed 文献 · Gastrointest Endosc · 2018-11-16

在亚太地区8个中心的无症状平均风险≥50岁人群中,比较直接筛查结肠镜(DSC)与粪便免疫化学检测阳性后结肠镜(FITC)的腺瘤检出率(ADR)、进展期腺瘤检出率(AADR)和每结肠镜腺瘤数(APC)。FITC的总体ADR、男性和女性特异性ADR及总体AADR均显著高于DSC,校正患者特征后差异仍显著。ADR与APC强正相关,ADR 45%和35%分别对应APC约1和约0.65。

要点

  • FITC总体ADR 53.6% vs DSC 37.5%(OR 1.93,P < .001)。
  • FITC总体AADR 29.9% vs DSC 4.9%(OR 8.2,P < .001)。
  • ADR与APC强正相关,ADR 45%和35%分别对应APC约1和约0.65。

核心结论

  • 这项国际多中心队列研究提供早期证据,表明新提出的更高ADR目标作为FITC的质量指标是合理的。

研究设计与样本

  • 国际多中心队列研究,纳入亚太地区8个中心的无症状平均风险≥50岁患者,其中DSC组2901例(平均年龄60.1岁,57%男性),FITC组2485例(平均年龄62.8岁,57%男性)。

主要发现

  • FITC总体ADR为53.6%,DSC为37.5%(OR 1.93,P < .001)。
  • FITC男性特异性ADR为61.6%,DSC为44.6%(OR 2,P < .001)。
  • FITC女性特异性ADR为43.2%,DSC为28.2%(OR 1.94,P < .001)。
  • FITC总体AADR为29.9%,DSC为4.9%(OR 8.2,P < .001)。
  • 校正患者特征后,上述差异仍显著;ADR与APC强正相关,ADR 45%和35%分别对应APC约1和约0.65。

关键数值与推荐

  • FITC总体ADR 53.6% vs DSC 37.5%(OR 1.93,P < .001)。
  • FITC男性特异性ADR 61.6% vs DSC 44.6%(OR 2,P < .001)。
  • FITC女性特异性ADR 43.2% vs DSC 28.2%(OR 1.94,P < .001)。
  • FITC总体AADR 29.9% vs DSC 4.9%(OR 8.2,P < .001)。
  • ADR 45%对应APC约1,ADR 35%对应APC约0.65。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Recent guidelines propose higher adenoma detection rate (ADR) benchmarks for colonoscopies performed for positive results for fecal immunochemical tests (FIT), but this is based on low-quality evidence. We aimed to compare ADR, advanced ADR (AADR), and number of adenomas per colonoscopy (APC) in direct screening colonoscopy (DSC) versus FIT-positive colonoscopy (FITC) in a multicenter Asia-Pacific cohort to justify differential targets. METHODS: Asymptomatic average-risk patients ≥50 years of age who underwent screening colonoscopy directly or as follow-up for positive OC-Sensor FIT results were identified from 8 sites across the Asia-Pacific region. Overall, sex-specific ADR, overall AADR, and overall APC were compared between the 2 screening methods. Multivariable logistic regression was performed to adjust for confounding by differences in patient characteristics. Linear regression was used to correlate ADR with APC and to propose APC benchmarks. RESULTS: A total of 2901 (mean age, 60.1 years; 57% men) individuals had DSC, and 2485 (mean age, 62.8 years; 57% men) underwent FITC. Overall ADR (53.6% vs 37.5%; odds ratio [OR], 1.93; P < .001), male-specific ADR (61.6% vs 44.6%; OR, 2; P < .001), female-specific ADR (43.2% vs 28.2%; OR, 1.94; P < .001) and overall AADR (29.9% vs 4.9%; OR, 8.2; P < .001) in FITC were significantly higher than the corresponding values for DSC. Differences remained significant after adjustment for patient characteristics. ADR was strongly and positively correlated to APC, with an ADR of 45% and 35% correlating to an APC of ∼1 and ∼0.65. CONCLUSIONS: Results from this international multicenter cohort study provide early evidence that newly proposed higher ADR targets are justified as quality indicators for FITC.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Wong JCT, Chiu HM, Kim HS, et al. Adenoma detection rates in colonoscopies for positive fecal immunochemical tests versus direct screening colonoscopies. Gastrointest Endosc. 2018. PMID: 30452915. doi:10.1016/j.gie.2018.11.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。